138 related articles for article (PubMed ID: 31500997)
21. Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a "joint action" mode toward DNA.
Qin X; Fang L; Chen F; Gou S
Eur J Med Chem; 2017 Sep; 137():167-175. PubMed ID: 28586717
[TBL] [Abstract][Full Text] [Related]
22. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells.
Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C
J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495
[TBL] [Abstract][Full Text] [Related]
23. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
24. Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo.
Shu L; Ren L; Wang Y; Fang T; Ye Z; Han W; Chen C; Wang H
Chem Commun (Camb); 2020 Mar; 56(20):3069-3072. PubMed ID: 32049075
[TBL] [Abstract][Full Text] [Related]
25. Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)].
Pérez JM; Kelland LR; Montero EI; Boxall FE; Fuertes MA; Alonso C; Navarro-Ranninger C
Mol Pharmacol; 2003 Apr; 63(4):933-44. PubMed ID: 12644595
[TBL] [Abstract][Full Text] [Related]
26. Platinum-Based Modification of Styrylbenzylsulfones as Multifunctional Antitumor Agents: Targeting the RAS/RAF Pathway, Enhancing Antitumor Activity, and Overcoming Multidrug Resistance.
Liu Z; Wang M; Wang H; Fang L; Gou S
J Med Chem; 2020 Jan; 63(1):186-204. PubMed ID: 31820986
[TBL] [Abstract][Full Text] [Related]
27. Dual-target platinum(IV) complexes exhibit antiproliferative activity through DNA damage and induce ER-stress-mediated apoptosis in A549 cells.
Wang M; Liu Z; Huang X; Chen Y; Wang Y; Kong J; Yang Y; Yu C; Li J; Wang X; Wang H
Bioorg Chem; 2021 May; 110():104741. PubMed ID: 33647739
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of bi-functional 7-hydroxycoumarin platinum(IV) complexes as antitumor agents.
Wang Q; Chen Y; Li G; Liu Z; Ma J; Liu M; Li D; Han J; Wang B
Bioorg Med Chem; 2019 May; 27(10):2112-2121. PubMed ID: 30981607
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of two novel anionic and cationic platinum complexes in the treatment of osteosarcoma.
Igarashi K; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Odani A; Tsuchiya H
Anticancer Agents Med Chem; 2015; 15(3):390-9. PubMed ID: 25511510
[TBL] [Abstract][Full Text] [Related]
31. Platinum(IV) complex with adamantylamine as nonleaving amine group: synthesis, characterization, and in vitro antitumor activity against a panel of cisplatin-resistant cancer cell lines.
Zák F; Turánek J; Kroutil A; Sova P; Mistr A; Poulová A; Mikolin P; Zák Z; Kasná A; Záluská D; Neca J; Sindlerová L; Kozubík A
J Med Chem; 2004 Jan; 47(3):761-3. PubMed ID: 14736257
[TBL] [Abstract][Full Text] [Related]
32. Combination of 7-hydroxycoumarin in a platinum(IV) complex derived from cisplatin enhanced cytotoxicity with multiple mechanisms of action.
Hua W; Zhao J; Hu W; Gou S
J Inorg Biochem; 2018 Sep; 186():17-23. PubMed ID: 29807243
[TBL] [Abstract][Full Text] [Related]
33. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
Chen H; Wang X; Gou S
J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
[TBL] [Abstract][Full Text] [Related]
34. Highly potent Platinum(IV) complexes with multiple-bond ligands targeting mitochondria to overcome cisplatin resistance.
Fang B; Chen X; Zhou X; Hu X; Luo Y; Xu Z; Zhou CH; Meng JP; Chen ZZ; Hu C
Eur J Med Chem; 2023 Mar; 250():115235. PubMed ID: 36863226
[TBL] [Abstract][Full Text] [Related]
35. Novel bis-platinum complexes endowed with an improved pharmacological profile.
Gatti L; Perego P; Leone R; Apostoli P; Carenini N; Corna E; Allievi C; Bastrup U; De Munari S; Di Giovine S; Nicoli P; Grugni M; Natangelo M; Pardi G; Pezzoni G; Singer JW; Zunino F
Mol Pharm; 2010 Feb; 7(1):207-16. PubMed ID: 19919086
[TBL] [Abstract][Full Text] [Related]
36. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.
Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D
Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330
[TBL] [Abstract][Full Text] [Related]
37. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
39. Luminescent Pt
Lázaro A; Balcells C; Quirante J; Badia J; Baldomà L; Ward JS; Rissanen K; Font-Bardia M; Rodríguez L; Crespo M; Cascante M
Chemistry; 2020 Feb; 26(9):1947-1952. PubMed ID: 31909511
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]